Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy. [electronic resource]
Producer: 20151006Description: 348-52 p. digitalISSN:- 1537-453X
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Chemotherapy, Adjuvant
- Cohort Studies
- Female
- Humans
- Lymph Nodes -- pathology
- Mastectomy
- Mastectomy, Segmental
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasm, Residual
- Radiotherapy, Adjuvant
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Retrospective Studies
- Risk Factors
- Trastuzumab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.